NCT06284343 The Gynecological Cancer Associated Thrombosis (GynCAT) Study
| NCT ID | NCT06284343 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Cancer-associated Thrombosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,800 participants |
| Start Date | 2024-04-15 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,800 participants in total. It began in 2024-04-15 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.
Eligibility Criteria
Inclusion Criteria: * Female sex; * Diagnosis of gynecologic neoplasm (ovarian, tubal, uterine, cervical, vaginal, vulvar neoplasm); * Planned new line of systemic antineoplastic treatment; * Age of 18 years or older; * Accordance of Informed Consent. Exclusion Criteria: * Pregnant or breastfeeding women; * Indication to receive therapeutic dose anticoagulant therapy (e.g., atrial fibrillation, mechanical heart valve); * Diagnosis of symptomatic VTE at the time of screening for enrollment.
Contact & Investigator
Roberto Pola, PhD; MD
PRINCIPAL INVESTIGATOR
Agostino Gemelli University Polyclinic Foundation IRCCS
Frequently Asked Questions
Who can join the NCT06284343 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Cancer-associated Thrombosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06284343 currently recruiting?
Yes, NCT06284343 is actively recruiting participants. Contact the research team at roberto.pola@policlinicogemelli.it for enrollment information.
Where is the NCT06284343 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT06284343 clinical trial?
NCT06284343 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is Roberto Pola, PhD; MD at Agostino Gemelli University Polyclinic Foundation IRCCS. The trial plans to enroll 1,800 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.